JP2010504910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010504910A5 JP2010504910A5 JP2009528741A JP2009528741A JP2010504910A5 JP 2010504910 A5 JP2010504910 A5 JP 2010504910A5 JP 2009528741 A JP2009528741 A JP 2009528741A JP 2009528741 A JP2009528741 A JP 2009528741A JP 2010504910 A5 JP2010504910 A5 JP 2010504910A5
- Authority
- JP
- Japan
- Prior art keywords
- packing
- satraplatin
- day
- pharmaceutical
- orally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012856 packing Methods 0.000 claims 33
- 190014017285 satraplatin Chemical compound 0.000 claims 29
- 229960005399 satraplatin Drugs 0.000 claims 29
- 239000003814 drug Substances 0.000 claims 24
- 239000003246 corticosteroid Substances 0.000 claims 14
- 238000002512 chemotherapy Methods 0.000 claims 8
- 206010062904 Hormone-refractory prostate cancer Diseases 0.000 claims 5
- 229940123237 Taxane Drugs 0.000 claims 5
- 230000003474 anti-emetic effect Effects 0.000 claims 5
- 239000002111 antiemetic agent Substances 0.000 claims 5
- 230000001394 metastastic effect Effects 0.000 claims 5
- 206010061289 metastatic neoplasm Diseases 0.000 claims 5
- 238000011393 cytotoxic chemotherapy Methods 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 3
- MFWNKCLOYSRHCJ-BTTYYORXSA-N granisetron Chemical compound C1=CC=C2C(C(=O)N[C@H]3C[C@H]4CCC[C@@H](C3)N4C)=NN(C)C2=C1 MFWNKCLOYSRHCJ-BTTYYORXSA-N 0.000 claims 3
- 229960003727 granisetron Drugs 0.000 claims 3
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims 3
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 2
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 229960001334 corticosteroids Drugs 0.000 claims 2
- 229960003668 docetaxel Drugs 0.000 claims 2
- 239000002895 emetic Substances 0.000 claims 2
- 229960001842 estramustine Drugs 0.000 claims 2
- FRPJXPJMRWBBIH-RBRWEJTLSA-N estramustine Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 FRPJXPJMRWBBIH-RBRWEJTLSA-N 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 229940126601 medicinal product Drugs 0.000 claims 2
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 claims 2
- 229960001156 mitoxantrone Drugs 0.000 claims 2
- 210000002784 stomach Anatomy 0.000 claims 2
- 229960003048 vinblastine Drugs 0.000 claims 2
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 claims 2
- 206010006002 Bone pain Diseases 0.000 claims 1
- 206010061818 Disease progression Diseases 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 229930012538 Paclitaxel Natural products 0.000 claims 1
- 208000009956 adenocarcinoma Diseases 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 230000005750 disease progression Effects 0.000 claims 1
- 238000001794 hormone therapy Methods 0.000 claims 1
- 230000001926 lymphatic effect Effects 0.000 claims 1
- 229960001592 paclitaxel Drugs 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 claims 1
- 229960004618 prednisone Drugs 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84694206P | 2006-09-24 | 2006-09-24 | |
| US90301407P | 2007-02-22 | 2007-02-22 | |
| US90318107P | 2007-02-23 | 2007-02-23 | |
| EP07114787A EP1905437A1 (en) | 2006-09-24 | 2007-08-22 | Treatment of pain using satraplatin |
| PCT/EP2007/060122 WO2008034910A1 (en) | 2006-09-24 | 2007-09-24 | Treatment of pain using satraplatin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010504910A JP2010504910A (ja) | 2010-02-18 |
| JP2010504910A5 true JP2010504910A5 (OSRAM) | 2011-02-24 |
Family
ID=38577465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009528741A Pending JP2010504910A (ja) | 2006-09-24 | 2007-09-24 | サトラプラチンを使用する疼痛の治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090325913A1 (OSRAM) |
| EP (2) | EP1905437A1 (OSRAM) |
| JP (1) | JP2010504910A (OSRAM) |
| AR (1) | AR063712A1 (OSRAM) |
| TW (1) | TW200820982A (OSRAM) |
| WO (1) | WO2008034910A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1905439A1 (en) * | 2006-09-24 | 2008-04-02 | GPC Biotech AG | Second line treatment of metastatic hormone refractory prostate cancer using satraplatin |
| CN104984356A (zh) * | 2015-05-14 | 2015-10-21 | 昆明贵研药业有限公司 | 赛特铂的环糊精复合物及制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1720540B1 (en) * | 2004-02-18 | 2008-06-11 | GPC Biotech AG | Satraplatin for treating resistant or refractory tumors |
| ES2327421T3 (es) * | 2005-03-11 | 2009-10-29 | Gpc Biotech Ag | Terapia antiproliferativa combinada que comprende satraplatino o jm118 y docetaxel. |
| EP1905439A1 (en) * | 2006-09-24 | 2008-04-02 | GPC Biotech AG | Second line treatment of metastatic hormone refractory prostate cancer using satraplatin |
-
2007
- 2007-08-22 EP EP07114787A patent/EP1905437A1/en not_active Withdrawn
- 2007-09-21 TW TW096135611A patent/TW200820982A/zh unknown
- 2007-09-24 JP JP2009528741A patent/JP2010504910A/ja active Pending
- 2007-09-24 EP EP07820528A patent/EP2066315A1/en not_active Withdrawn
- 2007-09-24 US US12/311,176 patent/US20090325913A1/en not_active Abandoned
- 2007-09-24 AR ARP070104208A patent/AR063712A1/es unknown
- 2007-09-24 WO PCT/EP2007/060122 patent/WO2008034910A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| Mehrabi et al. | Therapeutic agents in perioperative third molar surgical procedures | |
| JP2012522837A5 (OSRAM) | ||
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| JP2008530248A5 (OSRAM) | ||
| JP2010501575A5 (OSRAM) | ||
| JP2020516646A5 (OSRAM) | ||
| JP2016185995A5 (OSRAM) | ||
| JP2009545600A5 (OSRAM) | ||
| HRP20130961T1 (hr) | Kombinacije za tretman raka | |
| JP2012506448A5 (OSRAM) | ||
| TW201210593A (en) | Compositions and methods for treating centrally mediated nausea and vomiting | |
| CN107872975A (zh) | 用于治疗恶心和呕吐的氨磺必利和其它止吐药的组合 | |
| JP2013511507A5 (OSRAM) | ||
| JP2018507243A5 (OSRAM) | ||
| JP2010504307A5 (OSRAM) | ||
| JP2021509395A5 (OSRAM) | ||
| TWI441639B (zh) | 用於治療卵巢癌之包含紫杉醇之組合 | |
| RU2005141408A (ru) | Комбинированное применение эктеинасцидина-743 и содержащих платину противоопухолевых соединений | |
| CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
| JP2010538066A5 (OSRAM) | ||
| JP2012505830A5 (OSRAM) | ||
| JP2016505050A5 (OSRAM) | ||
| RU2011111792A (ru) | Применение парацетамола и ибупрофена в лечении | |
| JP2010504910A5 (OSRAM) |